Summary of Key Information:
Acquirer / Parent Company: Anlon Healthcare Limited
Target Company: ANLON HEALTHCARE NIGERIA LIMITED
Stock Exchange Listings:
NSE Scrip Code: AHCL
BSE Scrip Code: 544497
Nature of Transaction / Event: Incorporation of subsidiary company
Date of Transaction: 20/09/2026
Investment Details:
- Aggregate consideration: Naira 90,000,000 (Ninety Million Naira Only)
- Number of shares subscribed: 90,000,000 (Ninety Million) equity shares
- Face value per share: Naira 1 (One Naira Only)
- Mode of transaction: Banking channel subscription
Shareholding Structure:
- Anlon Healthcare Limited holds 90% of the subsidiary's share capital
- Total shares held: 90,000,000 equity shares
Subsidiary Company Details:
- Registration Number: 9874492
- Country of Incorporation: Nigeria
- Authorized share capital: Naira 100,000,000
- Paid-up share capital: Naira 100,000,000
- Industry: Pharmaceuticals, Healthcare, Personal Care, surgical implants and medical devices
- Business activities: Manufacturing, importing, processing, producing, trading, packaging, selling, blending of Active Pharmaceutical Ingredients (APIs), pharmaceutical bulk drugs, intermediates and Finished Dosage Formulations for human use, cosmetic and personal care products, surgical implants and medical devices
- Turnover: Nil (newly incorporated company)
- Business commencement: Yet to commence operations
Strategic Purpose:
The incorporation aligns with the Company's long-term growth objective to strategically complement and expand its existing business in the West African market. The subsidiary will provide access to 16 Western African Countries via its local entity.
Regulatory Compliance:
- Disclosure made under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
- Reference SEBI Circular: HO/49/14/14(7)2025-CFD-POD2/I/3762/2026 dated January 30, 2026
- Not a related party transaction
- No governmental or regulatory approvals required for incorporation
Company Information:
- CIN No.: L24230GJ2013PLC077543